Overview

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects

Status:
Completed

Trial end date:
2003-03-01

Target enrollment:

Participant gender:

Summary

To investigate the repeated dose Pharmacokinetics (PK) of transdermally delivered Rotigotine in Japanese and Caucasian female and male healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

UCB BIOSCIENCES GmbH

Treatments:

N 0437
Rotigotine